Last updated: June 24, 2026
The Office of the National Coordinator for Health Information Technology (ONC) defines health information exchange both as a verb, the act of sharing electronic health information, and as a noun, the organizations that facilitate that sharing. The national goal is a fully interoperable health system in which any authorized provider can access complete, accurate patient data at the point of care, regardless of where that data originated.
For cardiology, this matters because a single CIED patient may generate data across multiple OEM portals, an EHR, a billing platform, and a remote monitoring service. Without HIE infrastructure, that data never converges into a single actionable record, which limits clinical insight and slows response.
Three primary exchange models govern how clinical data moves between organizations:
The table below summarizes how each exchange model differs in data flow direction, cardiology use cases, and key constraints so you can match models to real-world scenarios in your practice.
| Exchange Type | Data Flow Direction | Cardiology Use Case | Key Limitation |
|---|---|---|---|
| Directed | Provider to provider (push) | Transmitting post-implant report to referring physician | Requires known recipient endpoint |
| Query-based | Provider to network (pull) | ED retrieves ICD history before cardioversion | Depends on network participation breadth |
| Patient-mediated | Patient-controlled aggregation | Patient shares remote monitoring log with new EP | Relies on patient engagement and literacy |
In practice, cardiology data normalization requires ingesting structured formats (HL7, XML, API feeds) alongside unstructured PDF reports from OEM portals. Standard HIE networks move this data but do not fully resolve these format differences without a dedicated execution layer inside the practice.
HIE participation operates within a layered compliance framework. HIPAA establishes the federal floor for permissible uses and disclosures of protected health information. State law often adds stricter requirements, particularly for mental health, substance use disorder, HIV/AIDS, and genetic data.
ONC's State Health IT Privacy and Consent Laws dataset classifies state HIE consent policies as opt-in, where explicit patient consent is required before data is stored or disclosed, or opt-out, where enrollment is automatic with the opportunity to decline. Some states use hybrid models. Multiple states impose requirements stricter than HIPAA by mandating patient authorization for mental health disclosures related to treatment, payment, or healthcare operations.
Two major HIE operators illustrate different approaches to patient opt-out rights. Contexture, the HIE operator serving Arizona and Colorado, allows patients to opt out at any time by informing their provider, after which their information is no longer accessible through Contexture's network. In contrast, Surescripts, registered as an HIE in Maryland, requires providers to inform patients of HIE participation in their Notice of Privacy Practices and accepts opt-out requests directly, though some information may remain available as required by law. This variation shows why cardiology practices must confirm each HIE's opt-out process rather than assuming a single standard.
For cardiology practices, the practical implication is clear. Patient notification must accompany HIPAA privacy notices, consent documentation must match the applicable state model, and sensitive data categories need additional authorization controls before transmission through any HIE network.
Common concerns about HIE participation include unauthorized data access, incomplete patient matching, data integrity errors during normalization, and liability exposure when downstream providers act on stale or incorrect records.
Provider organizations address these risks with role-based access controls, audit logging, system penetration testing, and advanced monitoring tools. Surescripts supplements HIPAA compliance with systems checks, audits, penetration testing, and advanced monitoring, and provides written breach notification to affected individuals with law enforcement reporting as required.
In cardiology-specific workflows, duration-only alert thresholds fail in device-detected atrial fibrillation because they compress a multi-dimensional clinical problem into a single number. This compression creates both false urgency and missed events. Structured escalation rules that incorporate electrogram confirmation and burden classification reduce this risk while preserving sensitivity.
The data silo risks outlined earlier persist when HIE participation is not paired with a normalized, single-source data layer at the practice level. Duplicate work, billing leakage, and audit exposure continue if teams still reconcile information across disconnected portals.
For patients with CIEDs, HIE directly affects the speed and completeness of clinical response. When device transmission data is accessible across care settings, an emergency physician can confirm a patient's ICD programming before treatment, and an electrophysiologist can identify a new arrhythmia between scheduled visits rather than waiting for the next in-person interrogation.
Medicare's remote patient monitoring framework requires devices to collect and transmit health data on at least 16 days every 30 days for billing under the relevant CPT codes. This requirement creates a minimum cadence for data availability that HIE infrastructure can distribute across the care team. Patients who opt out of HIE participation retain that right but forfeit the care coordination benefits that cross-organizational data sharing enables.
The Trusted Exchange Framework and Common Agreement (TEFCA), administered by ONC, establishes a universal policy and technical floor for nationwide HIE. By mid-2026, TEFCA's Qualified Health Information Networks (QHINs) are operational, enabling any participating organization to exchange data with any other participant regardless of network affiliation. This shift replaces a landscape of fragmented regional HIEs with a more consistent national fabric.
For cardiology practices, TEFCA's 2026 trajectory carries two practical implications. Query-based exchange becomes more reliable as QHIN participation expands, so device data and clinical records are more consistently retrievable across care settings. AI-driven data normalization also becomes necessary to make TEFCA-sourced data actionable at the point of care, because TEFCA governs transport and policy but does not standardize the clinical content or format of CIED-specific data streams.
Practices that establish a vendor-neutral execution layer now, one capable of ingesting HL7, XML, API, and PDF data formats, are positioned to use TEFCA's expanding network without rebuilding internal workflows as participation requirements evolve.
Practical HIE implementation in cardiology starts with data normalization across OEM portals. University of Chicago Medicine reviewed more than 73,000 reports annually through Rhythm360 in calendar year 2025, averaging more than 18,000 reports per quarter, which shows that high-volume CIED monitoring is operationally sustainable when data aggregation is centralized.
Rhythm360 by RhythmScience serves as the vendor-neutral execution layer for this workflow, addressing the fragmentation problem described earlier by ingesting data from all major OEMs (Medtronic, Boston Scientific, Abbott, Biotronik) via API, HL7, XML, and PDF parsing through computer vision, then normalizing those formats into a single dashboard. This normalization enables AI-powered alert triage to filter non-actionable transmissions before they reach clinical staff, which reduces critical response times by up to 80 percent and directly mitigates alert fatigue. Bi-directional EHR integration with Epic, Cerner, Athenahealth, and others removes manual transcription and supports automated CPT code documentation for the remote monitoring codes discussed earlier.
Schedule a demo to see how Rhythm360 unifies CIED and RPM data across your OEM portfolio.
Before selecting an HIE execution platform, cardiology practices should assess their current OEM portfolio, EHR system, and staffing model. Three questions help gauge readiness and shape implementation strategy. How many OEM portals does staff access daily, which reflects fragmentation? What is the average time from transmission receipt to clinician review, which reveals current response performance? Are CPT codes 93298 and 93299 captured for every eligible transmission, which highlights revenue leakage.
EHR integration timelines for modern platforms usually range from a few days to a few weeks. Staffing impact is typically positive, because centralized workflows reduce reliance on a single super-user and distribute monitoring responsibilities more evenly across the clinical team.
The most common implementation failures in cardiology HIE workflows involve four categories that often compound each other. Data silos persist when OEM portals are not fully integrated, leaving gaps in the unified record, which then worsens alert fatigue because incomplete normalization means non-actionable transmissions are not filtered before reaching clinical staff. This fragmentation also drives billing leakage, since CPT documentation that relies on manual tracking across disconnected portals inevitably misses eligible encounters. Finally, audit risk increases when communication logs and transmission reviews are stored in these same disconnected systems, creating no unified trail to demonstrate compliance during a review.
Duplicate data entry, manual report copying, and reconciliation across OEM portals and EHRs displace time that clinical staff would otherwise spend on direct patient care, a structural inefficiency that compounds as a practice's device population grows.
To confirm that HIE implementation delivers reduced administrative burden, faster critical response, and improved revenue capture, cardiology practices should track four KPIs that directly measure these outcomes:
Most cardiology practices benefit from HIE participation because it enables cross-organizational access to device histories, medication records, and prior imaging that would otherwise be unavailable when a patient presents at an unfamiliar facility. The decision depends on state consent model, patient population complexity, and the practice's ability to manage inbound data volume. Practices with high CIED populations and multi-site referral networks usually see the strongest operational return from participation.
Primary concerns include unauthorized data access, patient matching errors across organizations, data integrity loss during format normalization, and liability when downstream providers act on incomplete records. Secondary concerns involve state-specific consent compliance, particularly for sensitive data categories like mental health and substance use disorder records that require authorization beyond standard HIPAA permissions. These risks are mitigated through role-based access controls, audit logging, penetration testing, and a normalized single-source data layer at the practice level.
HIE enables faster clinical responses by making device data accessible across care settings, which allows emergency physicians to confirm ICD programming before treatment and electrophysiologists to identify arrhythmias between scheduled visits. Earlier identification can trigger interventions such as anticoagulation initiation, device reprogramming, or urgent evaluation instead of waiting for a quarterly in-person interrogation. Patients who opt out retain that right but lose these care coordination benefits.
TEFCA is the Trusted Exchange Framework and Common Agreement, administered by ONC, which establishes a universal policy and technical floor for nationwide health information exchange through Qualified Health Information Networks. In 2026, QHIN participation is operational, so cardiology practices connected to a QHIN can query patient records from any other participating organization regardless of network affiliation. For CIED workflows, TEFCA improves the availability of cross-organizational clinical context but does not standardize the format of device-specific data, which makes a vendor-neutral normalization layer necessary to translate TEFCA-sourced records into actionable clinical information.
The primary CPT codes for CIED remote monitoring are 93298 (remote monitoring of implantable cardiovascular monitor, 30-day period) and 93299 (remote monitoring of implantable loop recorder). For remote physiological monitoring of chronic conditions such as heart failure and hypertension, CPT 99454 covers device supply and daily recording or programmed alert transmission. Accurate capture of these codes requires automated documentation of transmission receipt, clinician review, and clinical decision-making, all of which depend on a centralized, auditable workflow rather than manual portal-by-portal tracking.
Cardiology practices evaluating an HIE execution platform should assess five criteria: vendor neutrality across all major OEMs, AI-powered alert triage that reduces non-actionable notifications before they reach clinical staff, bi-directional EHR integration with a go-live timeline measured in days rather than months, automated CPT documentation for 93298, 93299, and 99454, and HIPAA-compliant audit trails that satisfy both federal and state consent requirements. Practices that meet these criteria convert fragmented OEM data into a unified, actionable record, which reduces response times, captures lost revenue, and scales monitoring capacity without proportional staffing increases.
Schedule a demo to evaluate whether Rhythm360 meets these criteria for your practice.
